Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000036849 | SCV000060504 | benign | not specified | 2012-04-09 | criteria provided, single submitter | clinical testing | Ser182Ser in exon 6 of LDB3: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue and has been identified in 0.3% (22/6920) of European American chromosomes from a broad population by th e NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs714 73272). Ser182Ser in exon 6 of LDB3 (rs71473272; allele frequency = 0.3%, 22/69 20) ** |
Prevention |
RCV000036849 | SCV000306369 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000303793 | SCV000365576 | uncertain significance | Dilated Cardiomyopathy, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000365510 | SCV000365577 | uncertain significance | Left ventricular noncompaction cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000273098 | SCV000365578 | uncertain significance | Myofibrillar myopathy 4 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000307366 | SCV000365579 | uncertain significance | Myofibrillar Myopathy, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000273098 | SCV000557543 | benign | Myofibrillar myopathy 4 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000618735 | SCV000735180 | benign | Cardiovascular phenotype | 2015-07-31 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV001530015 | SCV001472062 | benign | not provided | 2023-09-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001530015 | SCV001838473 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001530015 | SCV003916616 | benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | LDB3: BP4, BP7, BS1, BS2 |
Cytogenetics- |
RCV001293331 | SCV001481919 | benign | Dilated cardiomyopathy 1C | 2015-01-30 | no assertion criteria provided | case-control | |
Diagnostic Laboratory, |
RCV001530015 | SCV001744503 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001530015 | SCV001799902 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000036849 | SCV001923348 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000036849 | SCV001953946 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000036849 | SCV001975957 | benign | not specified | no assertion criteria provided | clinical testing |